Gilder Gagnon Howe & Co’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Sell |
16,285
-74
| -0.5% | -$2.41K | 0.01% | 220 |
|
|
2025
Q1 | $618K | Sell |
16,359
-191
| -1% | -$7.21K | 0.01% | 201 |
|
|
2024
Q4 | $1.35M | Buy |
16,550
+42
| +0.3% | +$3.44K | 0.01% | 197 |
|
|
2024
Q3 | $1.89M | Sell |
16,508
-323
| -2% | -$36.9K | 0.02% | 187 |
|
|
2024
Q2 | $1.27M | Sell |
16,831
-247
| -1% | -$18.7K | 0.02% | 192 |
|
|
2024
Q1 | $1.17M | Sell |
17,078
-23
| -0.1% | -$1.57K | 0.01% | 207 |
|
|
2023
Q4 | $1.07M | Sell |
17,101
-5
| -0% | -$314 | 0.01% | 203 |
|
|
2023
Q3 | $872K | Buy |
17,106
+84
| +0.5% | +$4.28K | 0.01% | 214 |
|
|
2023
Q2 | $850K | Buy |
17,022
+3,454
| +25% | +$172K | 0.01% | 233 |
|
|
2023
Q1 | $509K | Sell |
13,568
-276
| -2% | -$10.3K | 0.01% | 220 |
|
|
2022
Q4 | $664K | Buy |
+13,844
| New | +$664K | 0.01% | 205 |
|